Ambicion

AMBICION Co., Ltd.

MENU

News

AMBICION participates in Regenerative Medicine JAPAN 2018

September 12, 2018

AMBICION participates in Regenerative Medicine JAPAN 2018 (held with Bio Japan 2018) as an exhibitor on October 10 to 12. (Booth number: R-22)
We’re looking forward to seeing you at our booth. For more information
Regenerative Medicine JAPAN 2018 ...

Ghent University and AMBICION Entered into a Patent Assignment Agreement on the US rights to the Galacto-pyranosyl compounds.

May 31, 2018

Ghent University (Ghent, Belgium) and AMBICION (Tokyo, Japan) announced that they entered into a patent assignment agreement on the US rights to the Galacto-pyranosyl compounds as developed by the groups of Prof. Serge Van Calnebergh and Prof. Dirk Elewaut.
According to the agreement, AMBICIO...

AMBICION has completed raising funds from Regional Health Care Industry Support Fund and TOHO HOLDINGS

April 18, 2018

AMBICION Co., Ltd. announced that it has completed raising funds from Regional Health Care Industry Support Fund and TOHO HOLDINGS CO., LTD. through third-party allocation of new shares.
With this capital increase, AMBICION accelerates its development programs of Natural Killer T (NKT) cell-t...
1 2